Request Demo
Last update 24 Jul 2026
Gan & Lee Pharmaceutical Shandong Co. Ltd.
Subsidiary Company|2019|Shandong Sheng, China
Subsidiary Company|2019|Shandong Sheng, China
Last update 24 Jul 2026
Overview
Tags
Digestive System Disorders
Neoplasms
Biological products
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20251051
评估受试制剂非奈利酮片（规格：10 mg）与参比制剂Kerendia®（规格：10 mg）在健康成年参与者餐后状态下的单中心、开放、随机、单剂量、两周期、两序列、双交叉生物等效性试验
[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, double-crossover bioequivalence study to evaluate the bioequivalence of the test product, finerenone tablets (strength: 10 mg), and the reference product, Kerendia® (strength: 10 mg), in healthy adult participants in the fed state.
CTR20251049
评估受试制剂非奈利酮片（规格：10 mg）与参比制剂Kerendia®（规格：10 mg）在健康成年参与者空腹状态下的单中心、开放、随机、单剂量、两周期、两序列、双交叉生物等效性试验
[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, double-crossover bioequivalence study to evaluate the bioequivalence of the test product, finerenone tablets (strength: 10 mg), and the reference product, Kerendia® (strength: 10 mg), in healthy adult participants under fasting conditions.
CTR20244885
达格列净片人体生物等效性研究
[Translation] Study on the bioequivalence of dapagliflozin tablets in human body
100 Clinical Results associated with Gan & Lee Pharmaceutical Shandong Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Gan & Lee Pharmaceutical Shandong Co. Ltd.
Login to view more data
100 Translational Medicine associated with Gan & Lee Pharmaceutical Shandong Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Sep 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
IND Application
IND Approval
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free